Abbott Laboratories (ABT) Stock

About Abbott Laboratories

Abbott Laboratories is led by CEO Robert Ford, employs 114,000 people, headquartered in Abbott Park, US, publicly traded since 1980.

Abbott Laboratories (ABT) stock trades at $104.88 with a market capitalization of $181.48B. The stock is valued at a price-to-earnings (P/E) ratio of 32.57, price-to-book of 3.45, price-to-sales of 3.76. Over the past 52 weeks the stock has ranged between $81.97 and $135.45, and currently trades 22.6% below its 52-week high. It pays a dividend yielding 2.49%.

On profitability, Abbott Laboratories generates a return on equity (ROE) of 10.52%, return on capital employed of 8.68%, an operating margin of 18.17%, a net profit margin of 11.65%.

In its most recent fiscal year, Abbott Laboratories reported annual revenue of $44.3B, net profit of $6.5B. Over the last 5 fiscal years, revenue grew at an average annual rate of 5.1%, and net profit grew at an average annual rate of 7.7%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.64, a current ratio of 1.58, total assets of $86.7B, $8.5B in cash and equivalents.

ABT has a beta of 0.59 (historically less volatile than the overall market).